Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

Israeli AI medical imaging Startup Aidoc Raises $66 Million

Aidoc founders – Michael Braginsky (left) Elad Walach, and Guy Reiner/ courtecy

Israeli startup Aidoc, which developed artificial intelligence (AI) for medical imaging, announced today a $66 million investment, led by General Catalyst.

This Series C financing, bringing the company’s total capital to more than $140 million, follows a rise in demand for Aidoc’s solutions, including the largest clinical deployment of AI in healthcare via its relationship with Radiology Partners.

Founded in 2016 by Michael Braginsky, Elad Walach, and Guy Reiner, Aidoc assists medical specialists in identifying acute irregularities in real-time. It has developed FDA-cleared artificial intelligence-based technologies that evaluate medical pictures for urgent conditions and generate alerts directly within the imaging workflow, thereby expediting treatment and improving overall patient quality of care. The company’s healthcare artificial intelligence platform is presently being used by radiologists in health networks, hospitals, and radiology groups worldwide and has evaluated over 8 million cases to date.

“This investment follows important milestones, including the expansion of our product lines, tripling our FDA certifications, and quadrupling our customer base,” said Elad Walach, co-founder and CEO of Aidoc. “We are undergoing rapid growth, which is also a direct outcome of C-level executives embracing an AI approach and integrating our platform as a required solution throughout therapeutic pathways. It’s an incredible privilege – and a tremendous duty – to be the trusted partner of the world’s most creative health systems and medical practices.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.